E. Blackstone, M. Morrison, and M. B. Roth, H2S induces a suspended animation-like state in mice, Science, vol.308, p.518, 2005.

E. M. Bos, R. Wang, P. M. Snijder, M. Boersema, J. Damman et al., Cystathionine g-Lyase Protects against Renal Ischemia/Reperfusion by Modulating Oxidative Stress, J Am Soc Nephrol, vol.24, pp.759-770, 2013.

H. Bracht, A. Scheuerle, M. Groger, B. Hauser, J. Matallo et al., Effects of intravenous sulfide during resuscitated porcine hemorrhagic shock, Crit Care Med, vol.40, pp.2157-2167, 2012.

W. Chai, Y. Wang, J. Y. Lin, X. D. Sun, L. N. Yao et al., Exogenous hydrogen sulfide protects against traumatic hemorrhagic shock via attenuation of oxidative stress, J Surg Res, vol.176, pp.210-219, 2012.

C. D. Collard and S. Gelman, Pathophysiology, clinical manifestations, and prevention of ischemia-reperfusion injury, Anesthesiology, vol.94, pp.1133-1138, 2001.

C. M. Farhana, B. M. Anuar, M. Murch, P. K. Bhatia, C. Moore et al., Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia, British Journal of Pharmacology, vol.146, pp.498-505, 2005.

T. Drabek, P. M. Kochanek, J. Stezoski, X. Wu, H. Bayir et al., Intravenous hydrogen sulfide does not induce hypothermia or improve survival from hemorrhagic shock in pigs, Shock, vol.35, pp.67-73, 2011.

J. W. Elrod, J. W. Calvert, and J. Morrison, Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function, Proc Natl Acad Sci U S A, vol.104, pp.15560-15565, 2007.

M. C. Shin,

M. Fish and M. G. Clemens, Hydrogen sulfide modulates sinusoidal constriction and contributes to hepatic micorcirculatory dysfunction during endotoxemia

, Am J Physiol Gastrointest Liver Physiol, vol.304, pp.1070-1078, 2013.

E. J. Norris, S. Larion, C. R. Culberson, and M. G. Clemens, Hydrogen sulfide differentially affects the hepatic vasculature in response to phenylephrine and endothelin 1 during endotoxemia, SHOCK, vol.39, issue.2, pp.168-175, 2013.

F. Ganster and M. Burban, Effects of hydrogen sulfide on hemodynamics, inflammatory response and oxidative stress during resuscitated hemorrhagic shock in rats, Critical Care, vol.14, issue.5, p.165, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00668446

C. Gao, D. Q. Xu, C. J. Gao, Q. Ding, L. N. Yao et al., An exogenous hydrogen sulphide donor, NaHS, inhibits the nuclear factor kappaB inhibitor kinase/nuclear factor kappab inhibitor/nuclear factor-kappaB signaling pathway and exerts cardioprotective effects in a rat hemorrhagic shock model, Biol Pharm Bull, vol.35, pp.1029-1034, 2012.

P. Goedhart and M. Khaliizada, Sidertream Dark Field (SDF) imaging : a novel stroboscopic LED ring-based imaging modality for clinical assessment of the microcirculation, Opt Express, vol.15, issue.23, pp.15101-15115, 2007.

G. Gutierrez, H. D. Reines, and M. E. Wulf-gutierrez, Clinical review: Hemorrhagic shock, Crit Care, vol.8, p.373, 2004.

J. D. House and M. E. Brosnan, Characterization of homocysteine metabolism in the rat kidney, Biochem. J, vol.328, pp.287-292, 1997.

I. Ishii and N. Akahoshi, Murine cystathionine gamma lyase complete cDNA and genomic sequences, promoter activity, tissue distribution and developmental expression, Biochem. J, vol.381, pp.113-123, 2004.

K. Issa, A. Kimmoun, S. Collin, F. Ganster, S. Fremont-orlowski et al., Compared effects of inhibition and exogenous administration of hydrogen sulphide in ischaemia-reperfusioninjury, Crit Care, vol.17, issue.4, p.129, 2013.

X. G. Justin, M. Zhu, Y. X. Kalbfl, R. Yang, I. Bihari et al., Detrimental effects of prolonged warm renal ischaemia-reperfusion injury are abrogated by supplemental hydrogen sulphide: an analysis using real-time intravital microscopy and polymerase chain reaction, B J U International, vol.110, pp.1218-1227, 2012.

D. W. Landry and J. A. Oliver, The pathogenesis of vasodilatory shock, N Engl J Med, vol.345, pp.588-595, 2001.

N. Li, Hyperhomocysteinemia Associated With Decreased Renal Transsulfuration Activity in Dahl S Rats, Hypertension, vol.47, issue.6, pp.1094-1100, 2006.

E. ?owicka and J. Be?towski, Hydrogen sulfide (H2S) -the third gas of interest for pharmacologists, Pharmacol Rep, vol.59, issue.1, pp.4-24, 2007.

M. A. Mariggiò, V. Minunno, and S. Riccardi, Sulfide enhancement of PMN apoptosis, Immunopharmacol Immunotoxicol, vol.20, pp.399-408, 1998.

S. Minamishima, M. Bougaki, and P. Y. Sips, Hydrogen sulfide improves survival after cardiac arrest and cardiopulmonary resuscitation via a nitric oxide synthase 3-dependent mechanism in mice, Circulation, vol.120, pp.888-896, 2009.

Y. Y. Mok, M. S. Atan, Y. Ping, C. , Z. Jing et al., Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis, Br J Pharmacol, vol.143, pp.881-889, 2004.

Y. Y. Mok and P. K. Moore, Hydrogen sulphide is pro-inflammatory in haemorrhagic shock, Inflamm Res, vol.57, pp.512-518, 2008.

M. L. Morrison, J. E. Blackwood, S. L. Lockett, A. Iwata, R. K. Winn et al., Surviving blood loss using hydrogen sulfide, J Trauma, vol.65, pp.183-188, 2008.

W. A. Pryor, K. N. Houk, C. S. Foote, J. M. Fukuto, L. J. Ignarro et al., Free radical biology and medicine: it's a gas, man!, Am J Physiol Regul Integr Comp Physiol, vol.291, pp.491-511, 2006.

R. Rossaint, B. Bouillon, V. Cerny, T. J. Coats, J. Duranteau et al., Management of bleeding following major trauma: an updated European guideline, Critical Care, vol.14, p.52, 2010.

F. Simon, A. Scheuerle, and M. Gröger, Effects of intravenous sulfide during porcine aortic occlusion-induced kidney ischemia/reperfusion injury, Shock, vol.35, pp.156-163, 2011.

A. Sivarajah, M. Collino, M. Yasin, E. Benetti, M. Gallicchio et al., Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R. Shock, vol.31, pp.267-274, 2009.

M. H. Stipanuk and P. W. Beck, Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat, Biochem. J, vol.206, pp.267-277, 1982.

C. Szabó, Hydrogen sulphide and its therapeutic potential, Nature Reviews Drug Discovery, vol.6, issue.11, pp.917-935, 2007.

G. Tang, L. Wu, W. Liang, and R. Wang, Direct Stimulation of KATP Channels by Exogenous and Endogenous Hydrogen Sulfide in Vascular Smooth Muscle Cells, Mol Pharmacol, vol.68, pp.1757-1764, 2005.

G. Thurston, J. S. Rudge, E. Zhou, H. Ross, L. Croll et al., Nat med, vol.6, pp.460-463, 2000.

P. Tripatara and N. Patel, Generation of endogenous hydrogen sulfide by cystathionine ?-lyase limits renal ischemia/reperfusion injury and dysfunction, Laboratory Investigation, vol.88, issue.10, pp.1038-1048, 2008.

A. Van-de-louw and P. Haouzi, Oxygen deficit and H2S in hemorrhagic shock in rats, Crit Care, vol.16, p.178, 2012.

F. Wagner and P. Asfar, Bench-to-bedside review: Hydrogen sulfide -the third gaseous transmitter: applications for critical care, Critical Care, vol.13, issue.3, p.213, 2009.

R. Wang, Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?, FASEB J, vol.16, pp.1792-1798, 2002.

C. Wiggers, Present status of shock problem, Physiol Rev, vol.22, pp.74-123, 1942.

H. T. Yuan, P. G. Tipping, X. Z. Li, D. A. Long, and A. S. Woolf, Angiopoietin correlates with glomerular capillary loss in anti-glomerular basement membrane glomerulonephritis, Kidney International, vol.61, pp.2078-2089, 2002.

W. Zhao and J. F. Ndisang, Modulation of endogenous production of H2S in rat tissues, Canadian Journal of Physiology and Pharmacology, vol.81, issue.9, pp.848-853, 2003.

W. Zhao, J. Zhang, Y. Lu, and R. Wang, The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener, EMBO J, vol.20, issue.21, pp.6008-6024, 2001.

C. Alessandria, A. Ottobrelli, W. Debernardi-venon, L. Todros, T. Cerenzia et al., Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, undlinded, pilot study, J Hepatol, vol.47, pp.499-505, 2007.

J. N. Benoit, J. A. Barrowman, S. L. Harper, P. R. Kvietys, and D. N. Granger, Role of humoral factors in the intestinal hyperemia associated with chronic portal hypertension, Am J Physiol, vol.247, p.48693, 1984.

J. N. Benoit, J. A. Barrowman, S. L. Harper, P. R. Kvietys, and D. N. Granger, Role of humoral factors in the intestinal hyperemia associated with chronic portal hypertension, Am J Physiol, vol.247, pp.486-93, 1984.

C. Bernadich, J. C. Bandi, P. Melin, and J. Bosch, Effect of F-180, a new selective vasoconstrictor peptide compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in rats model of portal hypertension, Hepatology, vol.27, pp.351-356, 1998.

A. T. Blei, R. J. Groszmann, R. Gusberg, and H. O. Conn, Comparison of vasopressin and triglycyl-lysine vasopressin on splanchnic and systemic hemodynamics in dogs, Dig Dis Sci, vol.25, pp.688-694, 1980.

L. Blendis and F. Wong, The hyperdynamic circulation in cirrhosis: an overview, Pharmacol Ther, vol.89, pp.221-231, 2001.

A. Bomzon and L. M. Blendis, Vascular reactivity in experimental portal hypertension, Am J Physiol, vol.252, pp.58-62, 1987.

A. Bomzon, G. Jacob, S. S. Lee, and J. Meddings, In vitro vascular responsiveness to norepinephrine in experimental portal hypertension, Clin Invest Med, vol.14, pp.63-71, 1991.

A. Bomzon and L. M. Blendis, The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis, Hepatology, vol.20, pp.1343-1350, 1994.

P. A. Cahill, M. Hou, S. Zhang, E. M. Redmond, and J. V. Sitzmann, Increased expression of endothelin receptors in hyperemic vessels from portal hypertensive rats, Hepatology, vol.24, p.317, 1996.

P. A. Cahill and Y. Wu, Sitzmann JV Altered adenylyl cyclase activities and G-protein abnormalities in portal hypertensive rabbits, J Clin Invest, vol.93, pp.2691-700, 1994.

A. Castro, W. Jimenez, J. Claria, R. J. Martinez, J. M. Bosch et al., Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide, Hepatology, vol.18, pp.367-72, 1993.

T. Cawley, J. Geraghty, H. Osborne, and J. R. Docherty, Effects of portal hypertension on responsiveness of rat mesenteric artery and aorta, Br J Pharmacol, vol.114, pp.791-796, 1995.

F. C. Chang, Y. T. Huang, H. C. Lin, C. Y. Hong, J. G. Lin et al., Beneficial effects of combined terlipressin and tetramethylpyrazine administration on portal hypertensive rats, Can J Physiol Pharmacol, vol.77, pp.618-624, 1999.

J. Claria, W. Jimenez, and R. J. , Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites, Hepatology, vol.20, pp.1615-1621, 1994.

M. Coll, J. Genesca, I. Raurell, A. Rodriguez-vilarrupla, M. Mejias et al., Down-regulation of genes related to the adrenergic system may contribute to splanchnic vasodilation in rat portal hypertension, J Hepatol, vol.49, pp.43-51, 2008.

M. Coll, M. Martell, I. Raurell, N. Ezkurdia, S. Cuenca et al., Atrophy of mesenteric sympathetic innervation may contribute to splanchnic vasodilation in rat portal hypertension, Liver International, vol.30, pp.593-602, 2010.

M. Coll, S. Rodriguez, I. Raurell, N. Ezkurdia, A. Brull et al., an Oral Norepinephrine Precursor, Improves Hemodynamic and Renal Alterations of Portal Hypertensive Rats, Hepatology, vol.56, pp.1849-59, 2012.

C. Connolly, T. Cawley, P. Mccormick, P. A. Docherty, and J. R. , Portal hypertension increases vasoconstrictor responsiveness of rat aorta, Clin Science, vol.96, pp.41-47, 1999.

S. A. Cummings, R. J. Groszmann, and A. J. Kaumann, Hypersensitivity of mesenteric veins to 5-hydroxytriptamine-and ketanserin-induced reduction of portal pressure in portal hypertensive rats, Br J Pharmacol, vol.89, pp.501-513, 1986.

C. Duvoux, D. Zanditenas, and C. Hezodec, Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study, Hepatology, vol.36, pp.374-380, 2002.

A. E. Farah, Glucagon and the circulation, Pharmacol Rev, vol.35, pp.181-217, 1983.

A. Fernandez-cruz, J. Marco, L. M. Cuadrado, J. Gutkowska, C. Caramelo et al., Plasma levels of atrial natriuretic factor in cirrhotic patients, Lancet, vol.ii, pp.1439-1440, 1985.

J. Finberg, H. A. Syrop, and O. S. Better, Blunted pressor response to angiotensin and sympathomimetic amines in bile duct-ligated dogs, Clin Sci Mol Med, vol.61, pp.535-544, 1981.

S. Fiorucci, E. Antonelli, V. Brancaleone, L. Sanpaolo, S. Orlandi et al., NCX-1000, a nitric oxidereleasing derivative of ursodeoxycholic acid, ameliorates portal hypertension and lowers norepinephrine-induced intrahepatic resistance in the isolated and perfused rat liver, J Hepatol, vol.39, pp.932-941, 2003.

M. L. Forsling, L. A. Aziz, R. Davies, B. Donovan, and M. Miller, Conversion of triglycylvasopressin to lysine-vasopressin in man, J Endocrinol, vol.85, pp.237-281, 1980.

R. Garcia, G. Thibault, N. Cantin, and G. Genest, Effect of a purified arterial natriuretic factor on rat and rabbit vascular strips and vascular beds, Am J Physiol, vol.247, pp.34-39, 1984.

G. Garcia-tsao, Portal hypertension, Curr Opin Gastroenterol, vol.19, pp.250-258, 2003.

S. Ghosh, N. Choudhary, K. Sharma, B. Singh, P. Kumar et al., Noradrenaline vs. terlipressin in the treatment of type 2 hepatorenal syndrome: a randomized pilot study, Liver Intern, vol.33, pp.1187-93, 2013.

A. Gimson, D. Westaby, J. Hegarty, A. Watson, and R. Williams, A randomized trial of vasopressin and vasopressin plus nitroglycerin in the treatment of acute variceal hemorrhage, Hepatology, vol.6, pp.410-413, 1986.

T. K. Gupta, M. Toruner, M. K. Chung, and R. J. Groszmann, Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats, Hepatology, vol.28, pp.926-931, 1998.

G. Hamilton, C. F. Phing, R. A. Hutton, P. Dandona, and E. F. Hobbs, The relationship between prostacyclin activity and pressure in the portal vein, Hepatology (Baltimore), vol.2, pp.236-242, 1982.

M. Hartleb, R. Moreau, S. Cailmail, C. Gaudin, and D. Lebrec, Vascular hyporesponsiveness to endothelin-1 in rats with cirrhosis, Gastroenterology, vol.107, pp.1085-93, 1994.

D. Hasper and A. Jörres, New insights into the management of hepato-renal syndrome, Liver Int, vol.31, issue.3, pp.27-30, 2011.

A. Heinemann, C. H. Wachter, P. Holzer, P. Fickert, and R. E. Stauber, Nitric oxide-dependent and -independent vascular hyporeactivity in mesenteric arteries of portal hypertensive rats, Br J Pharmacol, vol.121, pp.1031-1037, 1997.

J. Heller, M. Schepke, N. Gehnen, G. J. Molderings, A. Müller et al., Altered adrenergic responsiveness of endothelium-denuded hepatic arteries and portal veins in patients with cirrhosis, Gastroenterology, vol.116, pp.387-393, 1999.

J. F. Heubach, M. Blaschke, S. E. Harding, U. Ravens, and A. J. Kaumann, Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors, Naunyn Schmiedebergs Arch Pharmacol, vol.367, pp.380-90, 2003.

Y. T. Huang, H. C. Lin, P. C. Yu, F. Y. Lee, Y. T. Tsai et al., Decreased vascular reactivity of portal Hypertension vein in rats with portal, J Hepatology, vol.24, pp.194-199, 1996.

Y. T. Huang, L. Jw, H. C. Lin, Y. T. Tsai, C. Y. Hong et al., Change in vascular CAMP and cGMP contents in portal hypertensive rats, Pharmacology, vol.50, pp.86-91, 1995.

Y. T. Huang, J. F. Tsai, H. C. Lin, C. F. Chen, and C. Y. Hong, Hemodynamic effects of acute tetrandrine and terlipressin administration on portal hypertensive rats, Can J Physiol Pharmacol, vol.75, pp.1220-1225, 1997.

T. Joh, D. N. Granger, and J. N. Benoit, Intestinal microvascular responsiveness to norepinephrine in chronic portal hypertension, Am J Physiol, vol.260, p.3543, 1991.

S. Karatapanas, P. A. Mccormick, and S. Kakad, Alteration in vascular reactivity in isolated aortic rings from portal vein-constricted rats, Hepatology, vol.20, pp.1516-1521, 1994.

J. W. Kiel, V. Pitts, J. N. Benoit, D. N. Granger, and A. P. Shephard, Reduced vascular sensitivity to norepinephrine in portalhypertensive rats, Am J Physiol, vol.248, pp.92-97, 1985.

J. W. Kiel, V. Pitts, J. N. Benoit, D. N. Granger, and A. P. Shepherd, Reduced vascular sensitivity to norepinephrine in portal hypertensive rats, Am J Physiol, vol.248, pp.192-197, 1985.

G. Laffi, F. Marra, M. Failli-p-ruffiero, E. Cecchi, V. Carloni et al., Gentilini l? Defective signal transduction in platelets from cirrhotics is associated with increased cyclic nucleotides, Gastroenterology, vol.105, pp.148-56, 1993.

K. C. Lam, A. R. Tall, and G. B. Goldstein, Role of false neurotransmitter, octopamine, on the pathogenesis of hepatic and renal encephalopathy, Scand J Gastroenterol, vol.8, pp.464-472, 1973.

D. Lebrec, R. Moreau, S. Cailmail, P. Sogni, F. Oberti et al., Effects of terlipressin on hemodynamics and oxygen content in conscious portal vein-stenosed and cirrhotic rats receiving propranolol, J Hepatol, vol.17, pp.102-109, 1993.

D. Lebrec, Parmacological treatment of portal hypertension: hemodynamic effects and prevention of bleeding, Pharmacol Ther, vol.61, pp.65-107, 1994.

F. Y. Lee, C. J. Chu, S. S. Wang, F. Y. Chang, H. C. Lin et al., Inhibition of prostacyclin by indomethacin ameliorates the splanchnic hypoensitivity to glypressin in haemorrhage-transfused common bile ductligated rats, vol.31, pp.145-153, 2001.

S. S. Lee, C. Girod, A. Braillon, A. Hadengue, and D. Lebrec, Hemodynamic characterization of chronic bile duct-ligated rats: effect of pentobarbital sodium, Am J Physiol, vol.251, pp.176-180, 1986.

. Liao, P. C. Yu, H. C. Lin, F. Y. Lee, J. S. Kuo et al., Study on the vascular reactivity and ?1-adrenoceptor of portal hypertensive rats, Br J Pharmacol, vol.111, p.43944, 1994.

C. Merkel, A. Gatta, M. Bolognesi, G. Finucci, G. Battaglia et al., Hemodynamic changes of systemic, hepatic and splenic circulation following triglycyl-lysin-vasopressin administration in alcoholic cirrhosis, Dig Dis Sci, vol.33, pp.1103-1112, 1988.

C. L. Mesh, T. Joh, R. J. Korthuis, D. N. Granger, and J. N. Benoit, Intestinal vescular sensitivity to vasopressin in portal hypertensive rats, Gastroenterology, vol.100, pp.916-921, 1991.

P. P. Michielsen, G. E. Boeckxstaens, S. Su, A. G. Herman, and P. A. Pelckmans, The role of increased nitric oxide in the vascular hyporeactivity to noradrenaline in long-term portal vein ligated rats, J Hepatol, vol.23, pp.341-347, 1995.

M. J. Mulvany and W. Halpern, Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats, Circ Res, vol.41, pp.19-26, 1977.

B. M. Murray and M. S. Paller, Pressor resistance to vasopressin in sodium depletion, potassium depletion and cirrhosis, Am J Physiol, vol.251, pp.525-555, 1986.

Y. Narahara, H. Kanazawa, Y. Taki, Y. Kimura, M. Atsukawa et al., Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis, J Gastroenterol Hepatol, vol.24, pp.1791-1797, 2009.

A. Olivera, J. Gutkowska, D. Rodriguez-puyol, A. Fernandez-cruz, and J. M. Lopez-novoa, Plasma levels of atrial natriuretic peptide in rats with experimental cirrhosis of the liver before and acute volume expansion, In Diuretics Edited by J B Puschett, pp.267-269, 1987.

H. Orrego, A. Medline, L. M. Blendis, J. G. Rankin, and D. A. Kreaden, Collagenisation of the Disse space in alcoholic liver disease, Gut, vol.20, pp.673-682, 1979.

M. P. Pizcueta, R. Casamitjana, R. Bosch, and J. Rodes, Decreased systemic vascular sensitivity to norepinephrine in portal hypertensive rats: role of hyperglucagonism

, Am J Physiol, vol.258, pp.191-196, 1990.

V. Ralevic, R. T. Mathie, K. P. Moore, and G. Burnstock, Vasoconstrictor responsiveness of the rat mesenteric arterial bed in cirrhosis, Br J Pharmacol, vol.118, pp.435-441, 1996.

A. Rodriguez-vilarrupla, M. Fernandez, J. Bosch, and J. C. Gracia-pagan, Current concepts on the pathophysiology of portal hypertension, Ann Hepatol, vol.6, pp.28-36, 2007.

J. Ryan, S. Krishnankutty, G. Jennings, M. Elser, and F. Dudley, Impaired reactivity of the peripheral vasculature to pressor agents in alcoholic cirrhosis, Gastroenterology, vol.105, pp.1167-72, 1993.

P. Sharma, A. Kumar, B. C. Sharma, and S. K. Sarin, An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response, Am J Gastroenterol, vol.103, pp.1689-97, 2008.

C. C. Sieber and R. J. Groszmann, In vitro hyporeactivity to methoxamine in portal hypertensive rats: reversal by nitric oxide blockade, Am J Physiol, vol.262, pp.996-1001, 1992.

C. C. Sieber and R. J. Groszmann, Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats, Gastroenterology, vol.103, pp.235-239, 1992.

V. Singh, S. Ghosh, B. Singh, P. Kumar, N. Sharma et al., Noradrenalin vs. terlipressin in the treatment of hepatorenal syndrome: A randomized study, J Hepatol, vol.56, pp.1293-98, 2012.

J. V. Sitzmann, G. B. Bulkley, M. C. Mitchell, and K. Campbell, Role of prostacyclin in the splanchnic hyperemia contributing to portal hypertension, Ann Surg, vol.209, pp.322-329, 1989.

M. H. Tsai, Splanchnic and systemic vasodilatation: the patient, J Clin Gastroenterol, vol.41, issue.3, pp.266-271, 2007.

J. R. Vane, E. E. Anggard, and R. M. Botting, Regulatory functions of the vascular endothelium, N Engl J Med, vol.323, pp.27-37, 1990.

L. M. Villamediana, G. Dieguez, J. C. Santos, A. L. Garcia-villalon, C. Caramelo et al., Vascular reactivity to norepinephrine in rats with cirrhosis of the liver, Can J Physiol, vol.66, pp.567-572, 1988.

S. Walker, A. Stiehl, R. Raedsch, and B. Kommerell, Terlipressin in bleeding esophageal varices: a placebo-controlled double-blind study, Hepatology, vol.6, pp.112-117, 1986.

S. Walker, Vasoconstrictor therapy in bleeding esophageal varices, Hepatogastroenterology, vol.37, pp.538-543, 1990.

Z. Wu and J. N. Benoit, Nonreceptor-mediated intestinal vasoconstriction in portal hypertensive rats, Am J Physiol, vol.267, pp.370-375, 1994.

A. E. Freitas and A. A. , Hemorrhage produces abnormalities in lymphocyte function and lymphokine generation, J Immunol, vol.142, issue.3, pp.899-906, 1989.

E. Abraham, A. Carmody, R. Shenkar, and J. Arcaroli, Neutrophils as early immunologic effectors in hemorrhage-or endotoxemia-induced acute lung injury, Am J Physiol Lung Cell Mol Physiol, vol.279, pp.1137-1145, 2000.

J. G. Abraldes, Y. Iwakiri, M. Loureiro-silva, O. Haq, W. C. Sessa et al., Mild increases in portal pressure upregulate vascular endothelial growth factor and endothelial nitric oxide synthase in the intestinal microcirculatory bed, leading to a hyperdynamic state, Am J Physiol Gastrointest Liver Physiol, vol.290, pp.980-987, 2006.

A. Y. Abramov, A. Scorziello, and M. R. Duchen, Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation, J Neurosci, vol.27, pp.1129-1138, 2007.

C. Alessandria, A. Ottobrelli, W. Debernardi-venon, L. Todros, T. Cerenzia et al.,

F. , M. A. Rizzetto, M. Marzano, and A. , Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, undlinded, pilot study, J Hepatol, vol.47, pp.499-505, 2007.

A. W. Schlant, R. C. Fuster, V. O'rourke, R. A. Roberts, R. et al., Hurst's the heart, arteries and veins, 1998.

. Mcgraw-hill, Health Professional Division

M. Y. Ali, Y. Mok, L. Ling, M. Whiteman, M. Bhatia et al., Regulation of vascular nitric oxide in vitro and in vivo; a new role for endogenous hydrogen sulphide?, Br J Pharmaco, vol.149, pp.625-659, 2006.

U. Andersson, H. Wang, K. Palmblad, A. C. Aveberger, O. Bloom et al., High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes, J Exp Med, vol.192, issue.4, pp.565-70, 2000.

D. C. Angus, W. T. Linde-zwirble, J. Lidicker, G. Clermont, J. Carcillo et al., Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care, Crit Care Med, vol.29, issue.7, pp.1303-1313, 2001.

S. Asaka, Y. Shibayama, and K. Nakata, Pathogenesis of focal and random hepatocellular necrosis in endotoxemia: microscopic observation in vivo, Liver, vol.16, pp.183-190, 1996.

P. G. Baer and J. C. Giff, Hormonal systems and renal hemodynamics, Ann Rev Physiol, vol.42, pp.589-601, 1980.

A. Balian, La cirrhose et ces complications, ISBN, 2005.

D. E. Baranano, C. D. Ferris, and S. H. Snyder, Atypical neural messengers, Trends Neurosci, vol.24, pp.99-106, 2001.

J. Barroso-aranda, G. W. Schmid-schönbein, Z. B. Engler, and R. L. , Granulocytes and no-reflow phenomenon in irreversible hemorrhagic shock, Circ Res, vol.63, pp.437-484, 1988.

R. Baskar, L. Li, and P. K. Moore, Hydrogen sulfide-induces DNA damage and changes in apoptotic gene expression in human lung fibroblast cells, FASEB J, vol.21, pp.247-55, 2007.

R. Bataller and D. A. Brenner, Liver fibrosis, J Clin Invest, vol.115, pp.209-227, 2005.

L. Benvegnu and M. Gois,

S. Bocsato, Histoire naturelle de cirrhose compensée virale : une étude prospective de l'incidence et la hiérarchie des complications majeurs, vol.53, pp.744-749, 2004.

C. Bernadich, J. C. Bandi, P. Melin, and J. Bosch, Effect of F-180, a new selective vasoconstrictor peptide compared with terlipressin and vasopressin on systemic and splanchnic hemodynamics in rats model of portal hypertension, Hepatology, vol.27, pp.351-356, 1998.

M. P. Bevilacqua, J. S. Pober, G. R. Majeau, W. Fiers, R. S. Cotran et al., Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1, Proc Natl Acad Sci, vol.83, pp.1699-713, 1986.

H. Birkedal-hansen, M. W. Bodden, M. K. Windsor, L. J. Birkedal-hansen, B. Decarlo et al.,

J. A. Engler, Matrix metalloproteinases:a review, Crit Rev Oral Biol Med, vol.4, issue.2, pp.197-250, 1993.

E. Blackstone, M. Morrison, and M. B. Roth, H2S induces a suspended animation-like state in mice, Science, vol.308, p.518, 2005.

E. Blackstone and M. B. Roth, Suspended animation-like state protects mice from lethal hypoxia, Shock, vol.27, issue.4, pp.370-372, 2007.

C. Bode, V. Kugler, and J. C. Bode, Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess, J Hepatol, vol.4, pp.8-14, 1987.

E. C. Boerma, K. Mathura, P. Van-der-voort, P. E. Spronk, and C. Ince, Quantifying bedside-derived imaging of microcirculatory abnormalities in septic patients: a prospective validation study, Crit Care, vol.9, issue.6, pp.601-607, 2005.

A. Bomzon and L. M. Blendis, Vascular reactivity in experimental portal hypertension, Am J Physiol, vol.252, pp.58-62, 1987.

F. G. Bonanno, Clinical pathology of the shock syndromes, J Emerg Trauma Shock, vol.4, issue.2, p.233, 2011.

F. G. Bonanno, Physiopathology of shock, J Emerg Trauma Shock, vol.4, issue.2, pp.222-232, 2011.

F. R. Bond and G. Johnson, Vascular adrenergic interactions during hemorrhagic shock, Fed Proc, vol.44, pp.281-290, 1985.

J. Bonventre, Role of adhesion molecules in acute ischemic renal insufficiency, Nephrol, vol.19, p.57, 1998.

J. V. Bonventre and J. M. Weinberg, Recent advances in the pathophysiology of ischemic acute renal failure, J Am Soc Nephrol, vol.14, pp.2199-210, 2003.

E. M. Bos, H. Leuvenink, P. M. Snijder, N. J. Kloosterhuis, J. Hillebrands et al., Hydrogen sulfide-induced hypometabolism prevents renal ischemia/reperfusion injury, J Am Soc Nephrol, vol.20, pp.1901-1905, 2009.

E. M. Bos, R. Wang, P. M. Snijder, M. Boersema, J. Damman et al.,

G. Yang, H. Leuvenink, and H. Van-goor, Cystathionine g-Lyase Protects against Renal Ischemia/Reperfusion by Modulating Oxidative Stress, J Am Soc Nephrol, vol.24, pp.759-770, 2013.

J. Bosch, M. Pizcueta, and M. Fernandez, Hepatic, splanchnic, and systemic haemodynamic abnormalities in portal hypertension. In: Shields R ed. Balliere's clinical gastroenterology. Portal hypertension, pp.425-436, 1992.

A. J. Botha, F. A. Moore, E. E. Moore, A. Sauaia, A. Banerjee et al., Early neutrophil sequestration after injury: a pathogenic mechanism for multiple organ failure, J Trauma, vol.39, pp.411-417, 1995.

H. Bracht, A. Scheuerle, M. Gröger, B. Hauser, J. Matallo et al.,

P. Asfar, M. Matejovic, P. Möller, E. Calzia, C. Szabó et al.,

M. Wagner, F. Radermacher, P. Simon, and F. , Effects of intravenous sulfide during resuscitated porcine hemorrhagic shock, Crit Care Med, vol.40, issue.7, pp.1-11, 2012.

P. Brandtzaeg, L. Osnes, R. Ostevo, G. B. Joo, A. B. Westvik et al., Net inflammatory capacity of human septic shock plasma evaluated by a monocyte-based target cell assay: identification of interleukin-10 as a major functional deactivator of human monocytes, J Exp Med, vol.184, issue.1, pp.51-60, 1996.

D. Brealy, M. Brand, I. Hargreaves, S. Heales, J. Land et al., Association between mitochondrial dysfunction and severity and outcome of septic shock, Lancet, vol.360, issue.9328, pp.219-242, 2002.

M. Brezis, S. N. Heyman, and F. H. Epstein, Determinants of intrarenal oxygenation. II. Hemodynamic effects

, Am J Physiol, vol.267, pp.1059-1062, 1994.

F. G. Brivet, D. J. Kleinknecht, P. Loirat, P. Landais, B. Bedock et al., Acute renal failure in intensive care units. Causes, outcome, and prognostic factors of hospital mortality: a prospective, multicenter study, Crit Care Med, vol.24, pp.192-200, 1996.

A. K. Burroughs, The Hepatic Artery, Portal Venous System and Portal Hypertension: the Hepatic Veins and Liver in Circulatory Failure, Sherlock's Diseases of the Liver and Biliary System, vol.9, pp.152-209, 2011.

M. Buwalda and C. Ince, Opening the microcirculation: can vasodilators be useful in sepsis?, Intensive Care Med, vol.28, pp.1208-1225, 2002.

P. Cabrales, A. G. Tsai, and M. Intaglietta, Hemorrhagic shock resuscitation with carbon monoxide saturated blood. Resuscitation, vol.72, pp.306-318, 2007.

T. Calandra, B. Echtenacher, D. L. Roy, J. Pugin, C. N. Metz et al.,

R. and G. Mp, Protection from septic shock by neutralization of macrophage migration inhibitory factor, Nat Med, vol.6, pp.164-70, 2000.

T. Calandra, Pathogenesis of septic shoc: implications for prevention and treatment, J Chemother, vol.1, issue.1, pp.173-80, 2001.

G. Caliendo, G. Cirino, V. Santagada, and J. L. Wallace, Synthesis and biological effects of hydrogen sulfide (H2S): development of H2S-releasing drugs as pharmaceuticals, J Med Chem, vol.53, pp.6275-86, 2010.

A. Castro, W. Jimenez, J. Claria, R. J. Martinez, J. M. Bosch et al., Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide, Hepatology, vol.18, pp.367-72, 1993.

W. Chai, Y. Wang, J. Y. Lin, X. D. Sun, L. N. Yao et al., Exogenous hydrogen sulfide protects against traumatic hemorrhagic shock via attenuation of oxidative stress, J Surg Res, vol.176, issue.1, pp.210-219, 2012.

B. Champigneulle, A. Braillon, G. Kleber, C. Gaudin, S. Cailmail et al., Adenosine and hemodynamic alterations in cirrhotic rats, Am J Physiol, vol.260, pp.543-550, 1991.

F. C. Chang, Y. T. Huang, H. C. Lin, C. Y. Hong, J. G. Lin et al., Beneficial effects of combined terlipressin and tetramethylpyrazine administration on portal hypertensive rats, Can J Physiol Pharmacol, vol.77, pp.618-624, 1999.

I. H. Chaudry and A. Ayala, Hemorrhage and resuscitation: immunological aspects, Am J Physiol, vol.259, issue.4, pp.663-78, 1990.

X. L. Chen, Z. F. Xia, D. Wei, S. Han, D. F. Ben et al., Role of p38 mitogen-activated protein kinase in Kupffer cell secretion of the proinflammatory cytokines after burn trauma, Burns, vol.29, pp.533-539, 2003.

Y. Cheng, J. F. Ndisang, G. Tang, K. Cao, and R. Wang, Hydrogen sulfide-induced relaxation of resistance mesenteric artery beds of rats, Am J Physiol Heart Circ Physiol, vol.287, issue.5, pp.2316-2323, 2004.

E. Childs, K. F. Udobi, J. G. Wood, F. A. Hunter, D. M. Smalley et al., In vivo visualization of reactive oxidants and leukocyte-endothelial adherence following hemorrhagic shock, Shock, vol.18, issue.5, pp.423-430, 2002.

S. U. Christl, H. D. Eisner, G. Dusel, H. Kasper, and W. Scheppach, Antagonistic effects of sulfide and butyrate on proliferation of colonic mucosa: a potential role for these agents in the pathogenesis of ulcerative colitis, Digestive diseases and sciences, vol.41, issue.12, p.24772481, 1996.

J. Claria, W. Jimenez, and R. J. , Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites, Hepatology, vol.20, pp.1615-1621, 1994.

T. Clavel, M. Faley, A. Hesbert, D. Jargot, J. C. Protois et al., Sulfure d'hydrogène. INRS. Fiche toxicologique n°32, 1997.

J. Cohen, The immunopathogenesis of sepsis, Nature, vol.420, issue.6917, pp.885-91, 2002.

M. Coll, J. Genesca, I. Raurell, A. Rodriguez-vilarrupla, M. Mejias et al., Down-regulation of genes related to the adrenergic system may contribute to splanchnic vasodilation in rat portal hypertension, J Hepatol, vol.49, pp.43-51, 2008.

M. Coll, M. Martell, I. Raurell, N. Ezkurdia, S. Cuenca et al., Atrophy of mesenteric sympathetic innervation may contribute to splanchnic vasodilation in rat portal hypertension, Liver International, vol.30, pp.593-602, 2010.

M. Coll, S. Rodriguez, I. Raurell, N. Ezkurdia, A. Brull et al., an Oral Norepinephrine Precursor, Improves Hemodynamic and Renal Alterations of Portal Hypertensive Rats, Hepatology, vol.56, pp.1849-59, 2012.

M. Collin, F. B. Anuar, O. Murch, M. Bhatia, P. K. Moore et al., Inhibition of endogenous hydrogen sulfide formation reduces the organ injury caused by endotoxemia, Br J Pharmacol, vol.146, pp.498-505, 2005.

S. Collin and B. Levy, Pathophysiological mechanisms of vascular hyporesponsiveness in shock states Réanimation, vol.17, pp.101-110, 2008.

M. Colombat, S. Deleuze, and P. Callard, Glomerular lesions in adult patients, Nephrol Ther, vol.4, issue.7, pp.617-644, 2008.

D. Backer, D. Creteur, J. Preiseir, J. C. Dubois, M. J. Vincent et al., Microvascular blood flow is altered in patients with sepsis, Am J Respir Crit Care Med, vol.166, issue.1, pp.98-104, 2002.

D. Backer, D. Hollenberg, S. Boerma, C. Goedgart, P. Buchele et al., How to evaluate the microcirculation: report of a round table conference, Crit Care, vol.11, issue.5, p.101, 2007.

R. P. Dellinger, M. M. Levy, J. M. Carlet, J. Bion, M. M. Parker et al., Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, Crit Care Med, vol.36, issue.1, pp.296-327, 2008.

B. Deplancke and H. R. Gaskins, Hydrogen sulfide induces serum-independent cell cycle entry in nontransformed rat intestinal epithelial cells, Faseb J, vol.17, issue.10, pp.1310-1312, 2003.

J. E. Doeller, T. S. Isbell, G. Benavides, J. Koenitzer, H. Patel et al., Polarographic measurement of hydrogen sulfide production and consumption by mammalian tissues, Analytical biochemistry, vol.341, issue.1, pp.40-51, 2005.

R. Dombkowski, M. Russel, A. Schulman, M. Doellman, and K. Olson, Vertebrate phylogeny of hydrogen sulfide vasoactivity, Am J Physiol Regul Integr Comp Physiol, vol.288, pp.243-252, 2005.

D. C. Dorman, F. J. Moulin, B. E. Mcmanus, K. C. Mahle, R. A. James et al., Cytochrome oxidase inhibition induced by acute hydrogen sulfide inhalation: correlation with tissue sulfide concentrations in the rat brain, liver, lung, and nasal epithelium, Toxicol Sci, vol.65, issue.1, pp.18-25, 2002.

T. Drabek, P. M. Kochanek, J. Stezoski, X. Wu, H. Bayir et al., Intravenous hydrogen sulfide does not induce hypothermia or improve survival from hemorrhagic shock in pigs, Shock, vol.35, pp.67-73, 2011.

R. Drazenovic, R. W. Samsel, M. E. Wylam, C. M. Doerschuk, and P. T. Schumacker, Regulation of perfused capillary density in canine intestinal mucosa during endotoxemia, J Appl Physiol, vol.72, pp.259-65, 1992.

C. Duvoux, D. Zanditenas, and C. Hezodec, Effects of noradrenalin and albumin in patients with type I hepatorenal syndrome: a pilot study, Hepatology, vol.36, pp.374-380, 2002.

P. Elbers and C. Ince, Mechanisms of critical illness--classifying microcirculatory flow abnormalities in distributive shock, Crit Care, vol.10, issue.4, p.221, 2006.

P. Elbers and C. Ince, Mechanisms of critical illness--classifying microcirculatory flow abnormalities in distributive shock, Crit Care, vol.10, issue.4, p.221, 2006.

I. J. Elenkov, G. P. Wilder, R. L. Vizi, and E. S. , The sympathetic nerve -an integrative interface between two supersystems: the brain and the immune system, Pharmacol rev, vol.52, issue.4, pp.595-638, 2000.

J. W. Elrod, J. W. Calvert, and J. Morrison, Hydrogen sulfide attenuates myocardial ischemia-reperfusion injury by preservation of mitochondrial function, Proc Natl Acad Sci U.S.A, vol.104, pp.15560-15565, 2007.

G. A. Eppel, G. Bergström, W. P. Anderson, and R. G. Evans, Autoregulation of renal medullary blood flow in rabbits, Am J Physiol Regul Integr Comp Physiol, vol.284, pp.233-244, 2003.

A. Escorsell, J. Bandi, E. Moitinho, F. Feu, J. Carcia-pagan et al., Time profile of the haemodynamic effects of Terlipressine in portal hypertension, J of Hepatology, vol.26, pp.621-627, 1997.

A. Escorsell, R. Del-arbol, L. Planas, R. Albillos, A. Banares et al.,

J. Bosch and J. , Multicenter randomized controlled trial of Terlipressine vs sclerotherapy in the treatment of acute variceal bleeding: The Test study Hepatology, vol.32, pp.471-476, 2000.

C. T. Esmon, J. B. Taylor, and T. R. Snow, Inflammation and coagulation: linked processes potentially regulated through a common pathway mediated by protein C, Thromb Haemost, vol.66, pp.160-165, 1991.

S. Faller, S. W. Ryter, and A. M. Choi, Inhaled hydrogen sulfide protects against ventilator-induced lung injury, Anesthesiology, vol.113, pp.104-119, 2010.

J. Fan, A. Kapus, P. A. Marsden, Y. H. Li, G. Oreopoulos et al., Regulation of Toll-like receptor 4 expression in the lung following hemorrhagic shock and lipopolysaccharide, J Immunol, vol.168, pp.5252-5259, 2002.

G. C. Farrell and C. Z. Larter, Nonalcoholic fatty liver disease: from steatosis to cirrhosis, Hepatology, vol.43, pp.99-112, 2006.

F. Feu, R. Del-arbol, L. Banares, R. Olanas, R. Bosch et al., Double blind randomized controlled trial comparing Terlipressine and somatostatin for acute variceal haemorrhage, Gastroenterology, vol.11, pp.1291-1299, 1996.

J. Finberg, H. A. Syrop, and O. S. Better, Blunted pressor response to angiotensin and sympathomimetic amines in bile duct-ligated dogs, Clin Sci Mol Med, vol.61, pp.535-544, 1981.

M. P. Fink, Reactive oxygen species as mediators of organ dysfunction caused by sepsis, acute respiratory distress syndrome, or hemorrhagic shock: potential benefits of resuscitation with Ringer's ethyl pyruvate solution, Curr Opin Clin Nutr Metab Care, vol.5, pp.167-174, 2002.

S. Fiorucci, E. Distrurri, G. Cirino, and J. L. Wallace, The emerging roles of hydrogen sulfide in the gastrointestinal tract and liver, Gastroenterology, vol.131, pp.259-271, 2006.

C. Fiuza, M. Bustin, S. Talwar, M. Tropea, E. Gerstenberger et al., Suffredini AF Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells, Blood, vol.103, issue.7, pp.2652-60, 2003.

E. Fort, D. Sautereau, C. Sylvain, P. Ingrand, B. Pillegand et al., A randomized trial of Terlipressin plus nitroglycerin vs balloon tamponade in the control of acute variceal haemorrhage, Hepatology, vol.11, pp.678-681, 1990.

J. Foster and S. W. Curtiss, The regulation of lung elastin synthesis, Am J Physiol, vol.259, issue.2, pp.13-23, 1990.

J. G. Freeman, J. Barton, and R. Co, Haemodynamic responses to 1,25 and 2 mg of Terlipressine intravenously in man, Aliment Pharmacol Ther, vol.2, pp.361-367, 1988.

S. L. Friedman, Liver fibrosis -from bench to bedside, J Hepatol, vol.38, issue.1, pp.38-53, 2003.

M. M. Gadalla and S. H. Snyder, Hydrogen sulfide as a gasotransmitter, J Neurochem, vol.113, pp.14-26, 2010.

F. Ganster, M. Burban, M. De-la-bourdonnaye, L. Fizanne, O. Douay et al., Effects of hydrogen sulfide on hemodynamics, inflammatory response and oxidative stress during resuscitated hemorrhagic shock in rats, Crit Care, vol.14, p.165, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00668446

D. Garcia--compean, P. Blanc, J. M. Bories, J. Michel, D. Desperez et al., Treatment of active gastro-oesophageal variceal bleeding with terlipressin or hemostatic balloon in patients with cirrhosis. A randomized controlled trial, Arch Med Res, vol.28, pp.241-245, 1997.

G. García-tsao, Bacterial translocation: Cause or consequence of decompensation in cirrhosis, J Hepatol, vol.34, pp.150-155, 2001.

A. M. Geerts, A. S. De-vriese, E. Vanheule, H. Van-vlierberghe, S. Mortier et al., Increased angiogenesis and permeability in the mesenteric microvasculature of rats with cirrhosis and portal hypertension: an in vivo study, Liver Int, vol.26, pp.889-898, 2006.

S. Ghosh, N. Choudhary, K. Sharma, B. Singh, P. Kumar et al.,

V. Singh, Noradrenaline vs. terlipressin in the treatment of type 2 hepatorenal syndrome: a randomized pilot study, Liver Intern, vol.33, pp.1187-93, 2013.

P. T. Goedhart, M. Khalilzada, R. Bezemer, J. Merza, and C. Ince, Sidestream Dark Field (SDF) imaging: a novel stroboscopic LED ring-based imaging modality for clinical assessment of the microcirculation, Opt Express, vol.12, issue.23, pp.15101-15114, 2007.

P. J. Golden and T. G. Buchman, Uncoupling of biological oscillators: a complementary hypothesis concerning the pathogenesis of multiple organ dysfunction syndrome, Crit Care Med, vol.24, pp.1107-1123, 1996.

R. J. Gonzalez, E. E. Moore, D. J. Ciesla, W. L. Biffl, J. L. Johnson et al., Mesenteric lymph is responsible for post-hemorrhagic shock systemic neutrophil priming, J Trauma, vol.51, pp.1069-1072, 2001.

S. Gordon, Pattern recognition receptors : doubling up for the innate immune response, Cell, 2002.

A. Gougoux, Physiologie des reins et des liquides corporels. Editions Multimondes, pp.1-336, 2005.

I. Mimura and . Nangaku, The suffocating kidney : tubulointerstitial hypoxia in end-stage renal disease, Nature Rev Nephro, vol.6, pp.667-678, 2010.

E. V. Granowitz, B. D. Clark, J. Mancilla, and C. A. Dinarello, Interleukin-1 receptor antagonist competitively inhibits the binding of interleukin-1 to the type II interleukin-1 receptor, J Biol Chem, vol.266, issue.22, pp.14147-50, 1991.

W. Groner, J. W. Winkelman, A. G. Harris, C. Ince, G. J. Bouma et al., Orthogonal polarization spectral imaging: a new method for study the microcirculation, Nat Med, vol.5, pp.1209-1221, 1999.

R. Groszmann, D. Kravetz, and J. Bosch, Nitroglycerin improves the haemodynamic response to vasopressin in portal hypertension, Hepatology, vol.2, pp.757-762, 1982.

T. K. Gupta, M. Toruner, C. Mk, and R. J. Groszmann, Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats, Hepatology, vol.28, pp.926-931, 1998.

A. Hadengue, A. Gadano, and R. Moreau, Beneficial effects of a 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrom, J Hepatol, vol.29, pp.565-570, 1998.

A. Hadengue, . Gadano, E. Giostra, R. Moreau, D. Valla et al., Terlipressin in the treatment of hepatorenal syndrome : A double blind crossover study, Hepatology, vol.22, issue.A236, p.165, 1995.

M. Hartleb, R. Moreau, S. Cailmail, C. Gaudin, and D. Lebrec, Vascular hyporesponsiveness to endothelin-1 in rats with cirrhosis, Gastroenterology, vol.107, pp.1085-93, 1994.

G. Hasko, J. Linden, B. Cronstein, and P. Pacher, Adenosine receptors: therapeutic aspects for inflammatory and immune diseases, Nature Reviews Drug Discovery, vol.7, pp.759-770, 2008.

S. R. Heckbert and N. B. Vedder, Outcome after hemorrhagic shock in trauma patients, J Trauma, 1998.

H. Heitsch, S. Brovkovych, T. Malinski, and G. Wiemer, Angiotensin-(1-7)-stimulated nitric oxide and superoxide release from endothelial cells, Hypertension, vol.37, pp.72-76, 2001.

V. Hélène and . Biologie, Elsevier Masson SAS revue francophone de laboratoires, 2006.

J. H. Henriksen and S. Moller, Cardiac and systemic haemodynamic complications of liver cirrhosis, Scand Cardiovasc J, vol.43, issue.4, pp.218-243, 2009.

R. Hosoki, N. Matsuki, and H. Kimura, The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide, Biochemical and biophysical research communications, vol.237, issue.3, pp.527-531, 1997.

H. C. Huang, O. Haq, T. Utsumi, S. Sethasine, J. G. Abraldes et al., Intestinal and plasma VEGF levels in cirrhosis: the role of portal pressure, J Cell Mol Med, vol.16, pp.1125-1133, 2012.

Y. T. Huang, J. F. Tsai, H. C. Lin, C. F. Chen, and C. Y. Hong, Hemodynamic effects of acute tetrandrine and terlipressin administration on portal hypertensive rats, Can J Physiol Pharmacol, vol.75, pp.1220-1225, 1997.

O. Huet and J. Duranteau, Endothelial dysfunction: involvement of reactive oxygen species, Réanimation, vol.17, pp.387-92, 2008.

J. P. Hunter, S. A. Hosgood, M. Patel, R. Rose, K. Read et al., Effects of hydrogen sulphide in an experimental model of renal ischaemia-reperfusion injury, British Journal of Surgery, vol.99, pp.1665-1671, 2012.

C. Ichai and C. Giunti, On which renal haemodynamic and renal function parameters can we act to protect the kidney?, Ann Fr Anesth Rea, vol.24, pp.148-60, 2005.

C. Ince, Heterogeneity of the hypoxic state in rat heart is determined at capillary level, Am J Physiol, vol.264, issue.2, pp.294-301, 1993.

G. Ioannou, J. Doust, and D. C. Rockey, Terlipressine for acute oesophageal variceal hemorrhage.The Cochrane Library, vol.3, 2001.

Y. Iwakiri and R. J. Groszmann, The hyperdynamic circulation of chronic liver diseases: from the patient to the molecule, Hepatology, vol.43, pp.121-131, 2006.

Y. Iwakiri, V. Shah, and D. C. Rockey, Vascular pathobiology in chronic liver disease and cirrhosisCurrent status and future directions, vol.61, pp.912-924, 2014.

J. , Extracellular matrix remodeling and matrix metalloproteinases in the vascular wall during aging and in pathological conditions, Biomed Pharmacother, vol.57, pp.5-6, 2003.

M. Kajimura, R. Fukuda, R. M. Bateman, T. Yamamoto, and M. Suematsu, Interactions of multiple gastransducing systems: hallmarks and uncertainties of CO, NO, and H2S gas biology, Antioxidants & redox signaling, vol.13, issue.2, pp.157-192, 2010.

K. W. Kang, S. Y. Choi, and M. K. Cho, Thrombin induces nitric-oxide synthase via Galpha12/13-coupled protein kinase C-dependent I-kappaBalpha phosphorylation and JNK-mediated I-kappaBalpha degradation, J Biol Chem, vol.278, pp.17368-78, 2003.

A. Khan, M. M. Schuler, P. Mg, S. Yong, R. W. Coppock et al., Effects of hydrogen sulphide exposure on lung mitochondrial respiratory chain enzymes in rats, Toxicol. Appl. Pharmacol, vol.103, pp.482-90, 1990.

J. W. Kiel, V. Pitts, J. N. Benoit, D. N. Granger, and A. P. Shephard, Reduced vascular sensitivity to norepinephrine in portalhypertensive rats, Am J Physiol, vol.248, pp.92-97, 1985.

F. Kiil, Analysis of the tubuloglomerular feedback mechanism in renal autoregulation, Acta Physiol Scand, vol.174, pp.357-66, 2002.

Y. Kimura, R. Dargusch, D. Schubert, and H. Kimura, Hydrogen sulfide protects HT22 neuronal cells from oxidative stress, Antioxid Redox Signal, vol.8, pp.661-70, 2006.

S. M. Kinsella and J. P. Tuckey, Perioperative bradycardia and asystole: relationship to vasovagal syncope and the Bezole-Jarish reflex, Br J Anaesth, vol.86, issue.6, pp.859-68, 2001.

R. A. Kloner, C. E. Ganote, and R. B. Jennings, The « no-reflow » phenomenon after temporary coronary occlusion in the dog, J Clin Invest, vol.54, pp.1496-1508, 1974.

J. Koenitzer, S. Isbell, H. Patel, G. Beavides, D. Dickinson et al., Hydrogen sulfide mediates vasoactivity in an O2-dependant manner, Am J Physiol Heart Cir Physiol, vol.292, pp.1953-1960, 2007.

S. Koyama, M. Aibiki, K. Kanai, T. Fujta, and K. Miyakawa, Role of central nervous system in renal nerve activity during prolonged hemorrhagic shock in dogs, Am J Physiol, vol.254, issue.5, pp.761-770, 1988.

H. Laggner, M. Hermann, H. Esterbauer, M. K. Muellner, M. Exner et al., The novel gaseous vasorelaxant hydrogen sulfide inhibits angiotensin-converting enzyme activity of endothelial cells, J Hypertens, vol.25, issue.10, pp.2100-2104, 2007.

W. Laleman, A. Omasta, M. Van-de-casteele, M. Zeegers, V. Elst et al., A role for asymmetric dimethylarginine in the pathophysiology of portal hypertension in rats with biliary cirrhosis, Hepatology, vol.42, pp.1382-90, 2005.

D. W. Landry and J. A. Oliver, The pathogenesis of vasodilatory shock, N Engl J Med, vol.345, issue.8, pp.588-95, 2001.

C. Laplace, O. Huet, E. Vicaut, C. Ract, L. Martin et al., Endothelial oxidative stress induced by serum from patients with severe trauma hemorrhage, Intensive Care Med

I. Leblanc and L. Jacob, Protection rénale, Circulation régionale et agents vaso-actifs, pp.415-430, 1997.

F. Y. Lee, C. J. Chu, S. S. Wang, F. Y. Chang, H. C. Lin et al.,

S. D. Lee, Inhibition of prostacyclin by indomethacin ameliorates the splanchnic hypoensitivity to glypressin in haemorrhage-transfused common bile duct-ligated rats, vol.31, pp.145-153, 2001.

M. Legrand, E. G. Mik, G. M. Balestra, R. Lutter, R. Pirracchio et al., Fluid resuscitation does not improve renal oxygenation during hemorrhagic shock in rats, Anesthesiology, vol.112, pp.119-146, 2010.

S. R. Lentz, M. Tsiang, and J. E. Sadler, Regulation of thrombomodulin by tumor necrosis factor-alpha: comparison of transcriptional and posttranscriptional mechanisms, Blood, vol.77, pp.542-50, 1991.

M. Leone, A. Bourgoin, F. Antonini, J. Albanèse, and C. Martin, Which therapeutic propects in the septic syndrome? Ann Fr Anesth Rea, vol.22, pp.798-808, 2003.

N. Lerolle, D. Nochy, E. Guérot, P. Bruneval, J. Y. Fagon et al., Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration, Intensive Care Med, vol.36, issue.3, pp.471-479, 2010.

S. Levacher, P. Letoumelin, and D. Pateron, Early administration of Terlipressine plus glyceryl trinitrate to control active upper gastrointestinal bleeding in cirrhotic patients, Lancer, vol.346, pp.865-868, 1995.

M. Levi, E. De-jonge, T. Van-der-poll, and H. Cate, Thromb Haemost, vol.82, pp.695-705, 1999.

M. Levi, T. Cate, H. Van-der-poll, T. , V. Deventer et al., Pathogenesis of disseminated intravascular coagulation in sepsis, JAMA, vol.270, pp.975-984, 1993.

L. Li, P. Rose, and P. K. Moore, Hydrogen sulfide and cell signaling, Annual review of pharmacology and toxicology, vol.51, pp.169-187, 2011.

T. Li, B. Zhao, and C. Wang, Regulatory effects of hydrogen sulfide on IL-6, IL-8 and IL-10 levels in the plasma and pulmonary tissue of rats with acute lung injury, Exp Biol Med (Maywood), vol.233, pp.1081-1088, 2008.

J. Lindert, J. Werner, M. Redlin, H. Kuppe, H. Habazettl et al., OPS imaging of human microcirculation: a short technical report, J Vasc Res, vol.39, issue.4, pp.368-72, 2002.

S. Liu, R. T. Premont, C. D. Kontos, S. Zhu, and D. C. Rockey, A crucial role of GRK2 in regulation of endothelial cell nitric oxide synthase function in protal hypertension, Nature Med, vol.11, pp.952-960, 2005.

I. Lobb, J. Zhu, W. Liu, A. Haig, and Z. Lan, Hydrogen sulfide treatment ameliorates long-term renal dysfunction resulting from prolonged warm renal ischemia-reperfusion injury, Can Urol Assoc J, 2014.

R. Lopez, F. Roig, M. T. Llinas, and F. J. Salazar, Role of cyclooxygenase-2 in the control of renal haemodynamics and excretory function, Acta Physiol Scand, vol.177, pp.429-464, 2003.

J. C. Lopez-talavera, G. Cadelina, J. Olchowski, W. Merrill, and R. J. Groszmann, Thalidomide inhibits tumor necrosis factor alpha, decreases nitric oxide synthesis, and ameliorates the hyperdynamic circulatory syndrome in portal-hypertensive rats, Hepatology, vol.23, pp.1616-1637, 1996.

R. Loutzenhiser, K. Griffin, G. Williamson, and A. Bidani, Renal autoregulation: new perspectives regarding the protective and regulatory roles of the underlying mechanisms, Am J Physiol Regul Integr Comp Physiol, vol.290, pp.1153-67, 2006.

E. Lowicka and J. Beltowski, Hydrogen sulfide (H2S) -the third gas of interest for pharmacologists. Pharmacol Re, vol.59, pp.4-24, 2007.

E. Lowicka and J. Beltowski, Hydrogen sulfide (H2S) -the third gas of interest for pharmacologists. Pharmacol Re, vol.59, pp.4-24, 2007.

M. Lynn, I. Jeroukhimov, Y. Klein, and U. Martinowitz, Updates in the management of severe coagulopathy in trauma patients, Int Care Med, vol.28, issue.2, pp.241-248, 2002.

W. S. Madorin, C. M. Martin, and W. J. Sibbald, Dopexamine attenuates flow motion in ileal mucosal arterioles in normotensive sepsis, Crit Care Med, vol.27, pp.394-400, 1999.

B. Maier, R. Lefering, M. Lehnert, H. L. Laurer, W. I. Steudel et al., Early versus late onset of multiple organ failure is associated with differing patterns of plasma cytokine biomarker expression and outcome after severe trauma, Shock, vol.28, pp.668-674, 2007.

D. S. Majid, K. E. Said, and S. A. Omoro, Responses to acute changes in arterial pressure on renal medullary nitric oxide activity in dogs, Hypertension, vol.34, pp.832-838, 1999.

S. C. Malpas, R. G. Evans, G. A. Head, and E. V. Lukoshkova, Contribution of renal nerves to renal blood flow variability during hemorrhage, Am J Physiol Regul Integr Comp Physiol, vol.274, pp.1283-1294, 1998.

C. Martin and C. Boisson, Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin

, after septic shock, hemorrhagic shock, and severe trauma, Crit Care Med, vol.25, issue.11, pp.1813-1822, 1997.

C. Martin, L. Papazian, G. Perrin, P. Saux, and F. Gouin, Norepinephrine or dopamine for the treatment of hyperdynamic septic shock?, Chest, vol.103, issue.6, pp.1826-1831, 1993.

C. Martin, B. Riou, and B. Vallet, Physiologie humaine appliquée, Arnette, vol.17, pp.217-247, 2006.

D. L. Mattson, S. H. Lu, R. J. Roman, and C. Aw, Relationship between renal perfusion pressure and blood flow in different regions of the kidney, Am J Physiol Regul Integr Comp Physiol, vol.264, pp.578-583, 1993.

V. Maxime, C. Fitting, J. M. Cavaillon, and D. Annane, Corticoids normalize leukocyte production of macrophage migration inhibitory factor in septic shock, J Infect Dis, vol.191, pp.138-182, 2005.

P. A. Mayes, Précis de Biochimie HARPER, les Presses de l'Université laval édition, pp.122-156, 1989.

F. N. Minard and D. S. Grant, Hypothermia as a mechanism for drug-induced resistance to hypoxia, Biochem Pharmacol, vol.31, issue.7, pp.1197-203, 1982.

Y. Y. Mok, M. S. Atan, P. C. Yoke, J. W. Zhong, M. Bathia et al., Role of hydrogen sulphide in haemorrhagic shock in the rat: protective effect of inhibitors of hydrogen sulphide biosynthesis, Br J Pharmacol, vol.143, pp.881-889, 2004.

P. E. Molina, G. J. Bagby, and P. Stahls, Hemorrhage alters neuroendocrine, hemodynamic, and compartmentspecific TNF responses to LPS, Shock, vol.16, pp.459-465, 2002.

S. Moller, F. Bendtsen, and J. H. Henriksen, Splanchnic and systemic hemodynamic derangement in decompensated cirrhosis, Can J Gastroenterol, vol.15, issue.2, pp.94-106, 2001.

S. Moller, E. F. Hansen, K. Brinch, J. H. Henriksen, and F. Bendtsen, Central and systemic haemodynamic effects of Terlipressine in portal hypertensive patients, Liver, vol.20, pp.51-59, 2000.

S. Moller, Systemic haemodynamics in cirrhosis and portal hypertension with focus on vasoactive substances and prognosis, Dan Med Bull, vol.45, pp.1-14, 1998.

F. A. Moore and E. E. Moore, Evolving concepts in the pathogenesis of postinjury multiple organ failure

, Surg Clin North Am, vol.75, pp.257-277, 1995.

D. Morales, J. Madigan, S. Cullinane, J. Chen, M. Heath et al., Reversal by vasopressin of intractable hypotension in the late phase of hemorrhagic shock, Circ, vol.100, issue.3, 1999.

R. Moreau, F. Durand, T. H. Poynard, and C. H. Duhamel, Terlipressin in patients with cirrhosis and type I hepatorenal syndrome: A retrospective Multicenter Study, Gastroenterology, vol.122, pp.923-930, 2002.

R. Moreau and D. Lebrec, The use of vasoconstrictors in patients with cirrhosis: type 1 HRS and beyond, Hepatology, vol.43, pp.385-94, 2006.

R. Moreau, O. Soubrane, and A. Hadengue, Haemodynamic responses to the administration of Terlipressine alone and combined with nitroglycerin in patients with cirrhosis, Gastroenterol Clin Biol, vol.16, pp.680-686, 1992.

R. Moreau, Hepatorenal syndrome in patients with cirrhosis, J Gastroenterol Hepatol, vol.17, pp.739-786, 2002.

G. J. Murphy, M. G. Reynolds, and J. J. , The origin of matrix metalloproteinases and their familial relationships, FEBS Lett, 1991.

C. E. Murry, R. B. Jennings, and K. A. Reimer, Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium, Circulation, vol.74, issue.5, pp.1124-1160, 1986.

Y. Nakajima and N. Baudry, Microcirculation in intestinal villi: a comparison between hemorrhagic and endotoxin shock, Am J Respir Crit Care Med, vol.164, issue.8, pp.1526-1556, 2001.

S. Nakayama, G. C. Kramer, R. C. Carlsen, and J. W. Holcroft, Infusion of very hypertonic saline to bled rats: membrane potentials and fluid shifts, J Surg Res, vol.38, issue.2, pp.180-186, 1985.

C. F. Nathan, Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes, J Clin Invest, vol.137, issue.10, pp.3295-3303, 1986.

K. Nouette-gaulain, A. Quinart, T. Letellier, and F. Sztark,

, Ann Fr. Anesth. Reanim, vol.26, pp.319-352, 2007.

T. Nystul and M. Roth, Carbon monoxide-induced suspended animation protects agains hypoxic damage in Caenorhabditis elegans, PNAS, vol.101, issue.24, pp.9133-9136, 2004.

M. Odeh, E. Sabo, I. Srugo, and A. Oliven, Serum levels of tumor necrosis factor-alpha correlate with severity of hepatic encephalopathy due to chronic liver failure, Liver Int, vol.24, pp.110-116, 2004.

K. Ohashi, V. Burkart, S. Flohe, and H. Kolb, Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex, J Immunol, vol.164, pp.558-61, 2000.

G. D. Oreopoulos, J. Hamilton, S. B. Rizoli, J. Fan, Z. Lu et al., In vivo and in vitro modulation of intercellular adhesion molecule (ICAM)-1 expression by hypertonicity, Shock, vol.14, pp.409-414, 2000.

H. Orrego, A. Medline, L. M. Blendis, J. G. Rankin, and D. A. Kreaden, Collagenisation of the Disse space in alcoholic liver disease, Gut, vol.20, pp.673-682, 1979.

R. Ortega, P. Gines, J. Uriz, and B. Calahorra, Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: Results of a prospective , nonrandomized study, Hepatology, vol.36, issue.4, p.942, 2002.

P. Padilla and M. Roth, Oxygen deprivation causes suspended animation in the zebrafish embryo, PNAS, vol.98, issue.13, pp.7331-7335, 2001.

W. C. Parks and S. D. Shapiro, Matrix metalloproteinases in lung biology, Respir Res, vol.2, issue.1, pp.10-19, 2001.

J. L. Pascual, K. A. Khwaja, L. E. Ferri, B. Giannias, D. C. Evans et al.,

, Hypertonic saline resuscitation attenuates neutrophil lung sequestration and transmigration by diminishing leukocyte-endothelial interactions in a two-hit model of hemorrhagic shock and infection

, J Trauma, vol.54, pp.121-130, 2003.

, Pathophysiological mechanisms of vascular hyporesponsiveness in shock states, Réanimation, vol.17, pp.101-110, 2008.

P. B. Persson, Renal blood flow autoregulation in blood pressure control, Curr Opion Nephrol Hypertens, vol.11, pp.67-72, 2002.

M. Pinzani, S. Milani, D. Franco, R. Grappone, C. Caligiuri et al., Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells, Gastroenterology, vol.110, pp.534-548, 1996.

M. P. Pizcueta, R. Casamitjana, R. Bosch, and J. Rodes, Decreased systemic vascular sensitivity to norepinephrine in portal hypertensive rats: role of hyperglucagonism, Am J Physiol, vol.258, p.191, 1990.

P. J. Pockros, R. , and T. B. , Rapid diuresis in patients with ascites from chronic liver disease: The importance of peripheral edema, Gastroenterology, vol.90, p.1827, 1986.

K. H. Polderman, Induced hypothermia and fever control for prevention and treatment of neurological injuries, Lancet, vol.371, pp.1955-69, 2008.

T. Poynard, P. Bedossa, P. Opolon, O. The, . Metavir et al., Natural history of liver fibrosis progression in patients with chronic hepatitis C, Lancet, vol.349, pp.825-857, 1997.

G. A. Prathapasinghe, Y. L. Siow, and O. , Detrimental role of homocysteine in renal ischemia-reperfusion injury, AmJ Physiol Renal Physiol, vol.292, pp.1354-63, 2007.

S. Ramasamy, S. Singh, P. Taniere, M. J. Langman, and M. C. Eggo, Sulfide-detoxifying enzymes in the human colon are decreased in cancer and upregulated in differentiation, American journal of physiology, 2006.

R. J. Reiffenstein, W. C. Hulbert, and S. H. Roth, Toxicology of hydrogen sulfide, Annual review of pharmacology and toxicology, vol.32, pp.109-134, 1992.

D. C. Rockey, C. N. Housset, and S. L. Friedman, Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo, J Clin Invest, vol.92, pp.1795-804, 1993.

J. P. Roesner and D. A. Vagts, Protective effects of PARP inhibition on liver microcirculation and function after haemorrhagic shock and resuscitation in male rats, Intensive Care Med, vol.32, issue.10, pp.1649-57, 2006.

I. M. Roitt, J. Brostoff, and D. K. Male, Immunité anti-bactérienne et antifungique. Immunologie clinique, 4 ème édition

R. Rossaint, B. Bouillon, V. Cerny, T. J. Coats, J. Duranteau et al.,

, Management of bleeding following major trauma: an updated European guideline, Critical Care, vol.14, p.52, 2010.

J. Ryan, S. Krishnankutty, G. Jennings, M. Elser, and F. Dudley, Impaired reactivity of the peripheral vasculature to pressor agents in alcoholic cirrhosis, Gastroenterology, vol.105, pp.1167-72, 1993.

A. L. Salzman, . Vromena, A. Denenberg, C. Szabo, and K. , ATP)-channel inhibition improves hemodynamics and cellular energetics in hemorrhagic shock, Am J Physiol, vol.272, pp.688-94, 1922.

R. A. Santos, A. C. Simoes-e-silva, C. Maric, D. M. Silva, R. P. Machado et al., Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas, Proc Natl Acad Sci U S A, vol.100, pp.8258-8263, 2003.

P. L. Sappington, R. Yang, H. Yang, K. J. Tracey, R. L. Delude et al., HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice

, Gastroenterology, vol.123, issue.3, pp.790-802, 2002.

A. Sarkis, K. L. Liu, M. Lo, and D. Benzoni, Angiotensin II and renal medullary blood flow, Am J Physiol Renal Physiol, vol.284, pp.365-372, 2002.

A. Sawadogo, N. Dib, and P. Calès, Physiopathology of cirrhosis and its complications, Réanimation, vol.16, pp.557-562, 2007.

J. C. Schadt and J. Ludbrook, Hemodynamic and neurohumoral responses to acute hypovolemia in conscious mammals, Am J Physiol, vol.260, pp.305-318, 1991.

R. Schlichtig, D. J. Kramer, and M. R. Pinski, Flow redistribution during progressive hemorrhage is a determinant of critical O2 delivery, J App Phsiol, vol.70, pp.169-78, 1991.

M. D. Schwartz, J. E. Repine, and A. E. , Xanthine oxidase-derived oxygen radicals increase lung cytokine expression in mice subjected to hemorrhagic shock, Am J Respir Cell Mol Biol, vol.12, pp.434-440, 1995.

R. M. Senior, G. G. Fliszar, C. J. Shapiro, S. D. Goldberg, G. L. Welgus et al., Human 92-and 72-kilodalton type IV collagenases are elastases, J Biol Chem, vol.266, issue.12, pp.7870-7875, 1991.

A. K. Sethi, P. Sharma, M. Mohta, and A. Tyagi, Shock -a short review, Indian J Anaesth, vol.47, issue.5, pp.345-359, 2003.

V. Shah, M. Toruner, F. Haddad, P. Cadelina, A. Papapetropoulos et al., Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat, Gastroenterology, vol.117, pp.1222-1230, 1999.

P. Sharma, A. Kumar, B. C. Sharma, and S. K. Sarin, An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response, Am J Gastroenterol, vol.103, pp.1689-97, 2008.

M. A. Sharpe and C. E. Cooper, Interaction of peroxynitrite with mitochondrial cytochrome oxidase. Catalytic production of nitric oxide and irreversible inhibition of enzyme activity, J Biol Chem, vol.273, pp.30961-30972, 1998.

T. Sharshar, F. Gray, L. De-la-grandmaison, G. Hopkinson, N. S. Ross et al.,

, Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock, Lancet, vol.362, pp.1799-805, 2003.

Y. Shibayama and K. Nakata, Localization of increased hepatic vascular resistance in liver cirrhosis, Hepatology, vol.5, pp.643-651, 1985.

N. Shibuya, Y. Mikami, Y. Kimura, N. Nagahara, H. Kimura et al., 3Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain, Antioxidants & redox signaling, vol.146, issue.5, pp.703-714, 2009.

S. Siberngal,

F. Lang, Atlas de poche de physiopathologie Ed, vol.11, pp.172-173, 2000.

C. C. Sieber and R. J. Groszmann, In vitro hyporeactivity to methoxamine in portal hypertensive rats: reversal by nitric oxide blockade, Am J Physiol, vol.262, pp.996-1001, 1992.

C. Silva, L. S. Ines, and D. Nour, Differential male and female adrenal cortical steroid hormone and cortisol responses to interleukin-6 in humans, Ann N Y Acad Sci, vol.966, pp.68-72, 2002.

F. Simon, A. Scheuerle, M. Gröger, B. Stahl, U. Wachter et al.,

C. Szabo, H. Schelzig, M. Georgieff, P. Radermacher, and F. Wagner, Effects of intravenous sulfide during porcine aortic occlusion-induced kidney ischemia/reperfusion injury, Shock, vol.35, issue.2, pp.156-63, 2011.

M. Singer, D. Santis, V. Vitale, D. Jeffcoate, and W. , Multiorgan failure is an adaptative, endocrinemediated, metabolic response to overwhelming systemic inflammation, Lancet, vol.364, pp.545-553, 2004.

P. Singh and S. C. Thomson, Renal homeostasis and tubuloglomerular feedback, Curr Opin Nephrol Hypertens, vol.19, issue.1, pp.59-64, 2010.

V. Singh, S. Ghosh, B. Singh, P. Kumar, N. Sharma et al.,

, J Hepatol, vol.56, pp.1293-98, 2012.

A. Sivarajah, M. Collino, and M. Yasin, Anti-apoptotic and anti-inflammatory effects of hydrogen sulfide in a rat model of regional myocardial I/R. Shock, vol.31, pp.267-74, 2009.

P. Solanki, A. Chawla, R. Garg, R. Gupta, M. Jain et al., Beneficial effects of terlipressin in hepatorenal syndrome: A prospective ,randomized placebo-controlled clinical trial, J of Gastroenterology and Hepatology, vol.18, p.152, 2003.

P. E. Spronk, D. F. Zandstra, and C. Ince, Bench-to-bedside review: sepsis is a disease of the microcirculation, Crit Care, vol.8, pp.462-470, 2004.

. Stadlbauerkh, H. G. Wagner-berger, C. Raedler, W. G. Voelckel, V. Wenzel et al., Vasopressin, but not fluid resuscitation, enhances survival in a liver trauma model with uncontrolled and otherwise lethal hemorrhagic shock in pigs, Anesthesiology, vol.98, issue.3, pp.699-704, 2003.

R. N. Stephan, T. S. Kupper, A. S. Geha, A. E. Baue, and I. H. Chaudry, Hemorrhage without tissue trauma produces immunosuppression and enhances susceptibility to sepsis, Arch Surg, vol.122, issue.1, pp.62-70, 1987.

R. M. Stewart, J. G. Myers, D. L. Dent, P. Ernis, G. A. Gray et al., Seven hundred fifty-three consecutive deaths in a level I trauma center: the argumant for injury prevention, J Trauma, vol.1, pp.70-71, 2003.

C. Szabo, Hydrogen sulfide and its therapeutic potential. Nat Rev Drug, 2007.

J. Takala, Dterminants of splanchnic blood flow, Br J Anaesth, vol.77, 1996.

F. Tamion, V. Richard, Y. Lacoume, and C. Thuillez, Intestinal preconditioning prevents systemic inflammatory response in hemorrhagic shock. Role of HO-1, Am J Physiol Gastrointest Liver Physiol, vol.283, pp.408-414, 2002.

S. Taoka and R. Banerjee, Characterization of NO binding to human cystathionine betasynthase: possible implications of the effects of CO and NO binding to the human enzyme, Journal of inorganic biochemistry, vol.87, issue.4, pp.245-251, 2001.

L. S. Terada, Oxidative stress and endothelial activation, Crit Care Med, vol.30, pp.186-191, 2002.

P. Tripatara, N. S. Patel, M. Collino, M. Gallicchio, J. Kieswich et al., Generation of endogenous hydrogen sulfide by cystathionine gamma-lyase limits renal ischemia/reperfusion injury and dysfunction, Lab Invest, vol.88, pp.1038-1086, 2008.

L. Ulloa, M. Ochani, H. Yang, M. Tanovic, D. Halperin et al., Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation, Proc Natl Acad Sci, vol.99, pp.12351-12357, 2002.

F. Vachiery, R. Moreau, and . Gadanoa, Hemodynamic and metabolic effects of Terlipressine in patients with cirrhosis receiving a non selective beta-blocker, Dig Dis Sci, vol.41, pp.1722-1726, 1996.

D. Valla, S. Lee, R. Moreau, A. Hadengue, and L. Sayegh, Effects de la terlipressine sur les circulations splanchnique et systémique des malades atteints de cirrhose, Gastroenterology Clin Biol, vol.9, pp.877-880, 1985.

L. S. Vallad, R. Moreau, A. Hadengue, and L. Sayegh, Effets de la terlipressine sur les circulations splanchnique et systémique des malades atteints de cirrhose, Gastroenterology Clin Biol, vol.9, pp.877-880, 1985.

B. Vallet, Endothelial cell dysfunction and abnormal tissue perfusion, Crit Care Med, vol.30, pp.229-263, 2002.

V. Vallon, B. Mühlbauer, and H. Osswald, Adenosine and kidney function, Physiol Rev, vol.86, pp.901-941, 2006.

C. Van-steenkiste, A. Geerts, E. Vanheule, H. Van-vlierberghe, D. Vos et al., Role of placental growth factor in mesenteric neoangiogenesis in a mouse model of portal hypertension, Gastroenterology, vol.137, pp.2111-2116, 2009.

S. F. Vatner, Effects of hemorrhage on regional blood flow distribution on dogs and primates, J Clin Invest, vol.54, issue.2, pp.225-260, 1974.

M. G. Vervloet, L. G. Thijs, and C. E. Hack, Derangement of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock, Semin Thromb Hemost, vol.24, issue.1, pp.33-44, 1998.

J. Vosmik, . Jedlika, and C. Mulder, Action of the triglycyl hormonogen of vasopressin (Glypressine) in patients with liver cirrhosis and bleeding oesophageal varices, Gastroenterology, vol.72, pp.605-609, 1977.

A. Waage, T. Espevik, and J. Lamvik, Detection of tumour necrosis factor-like cytotoxicity in serum from patients with septicaemia but not from untreated cancer patients, Scand J Immunol, vol.24, issue.6, pp.739-782, 1986.

F. Wagner, P. Asfar, E. Calzia, P. Radermacher, and C. Szabó, Hydrogen sulfide -the third gaseous transmitter: applications for critical care, Crit Care, vol.13, issue.3, p.213, 2009.

K. Wagner, M. Georgieff, P. Asfar, E. Calzia, M. W. Knoferl et al., Of mice and men (and sheep, swine, etc.): the intriguing hemodynamic and metabolic effects of hydrogen sulfide (H2S), Crit Care, vol.15, p.146, 2011.

S. Walker, H. P. Kreichgauer, and J. C. Bode, Terlipressine versus somatostatin in the treatment of bleeding oesophageal varices -final report of a placebo-controlled, double-blind study, Zeitschrift fur Gastroenterology, vol.34, p.692, 1996.

R. Wang, Two's company, three's a crowd: can H2S be the third endogenous gaseous transmitter?, FASEB J, vol.16, pp.1792-1798, 2002.

T. S. Wang and J. C. Deng, Molecular and cellular aspects of sepsis-induced immunosuppression, J Mol Med, vol.86, pp.495-506, 2008.

M. W. Warenycia, L. R. Goodwin, C. G. Benishin, R. J. Reiffenstein, D. M. Francom et al., Acute hydrogen sulfide poisoning: Demonstration of selective uptake of sulfide by the brainstem by measurement of brain sulfide levels, Biochem Pharmacol, vol.38, pp.973-81, 1989.

Z. Werb, Proteinases and matrix degradation, Textbook of Rheumatology, pp.300-321, 1989.

C. J. Wiggers, Basic hemodynamic principles essential to interpretation of cardiovascular disorders, Bull N.Y Acad Med, vol.18, issue.1, pp.3-17, 1942.

M. Xia, L. Chen, R. W. Muh, P. L. Li, and N. Li, Production and actions of hydrogen sulfide, a novel gaseous bioactive substance, in the kidneys, J Pharmacol Exp Ther, vol.329, pp.1056-62, 2009.

Z. Xu, G. Prathapasinghe, . Wun, S. Y. Hwang, and Y. L. Siow, Ischemia-reperfusion reduces cystathioninebetasynthase-mediated hydrogen sulfide generation in the kidney, Am. J. Physiol. Renal Physiol, vol.297, pp.27-35, 2009.

C. Yalamanchili and M. D. Smith, Acute hydrogen sulfide toxicity due to sewer gas exposure, Am J Emerg Med, vol.26, pp.518-523, 2008.

G. Yang, X. Sun, and R. Wang, Hydrogen sulfide-induced apoptosis of human aorta smooth muscle cells via the activation of mitogen-activated protein kinases and caspase-3, FASEB J, vol.18, pp.1782-1786, 2004.

G. Yang, L. Wu, and R. Wang, Pro-apoptotic effect of endogenous H2S on human aorta smooth muscle cells, FASEB J, vol.20, pp.553-558, 2006.

H. Yang, M. Ochani, J. Li, X. Qiang, M. Tanovic et al., Reversing established sepsis with antagonists of endogenous high-mobility group box 1, Proc Natl Acad Sci, vol.101, issue.1, pp.296-301, 2004.

R. Yang, X. Han, T. Uchiyama, S. K. Watkins, A. Yaguchi et al., IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice, Am J Physiol Gastrointest Liver Physiol, vol.285, pp.621-630, 2003.

R. C. Zanardo, V. Brancaleone, and E. Distrutti, Hydrogen sulfide is an endogenous modulator of leukocytemediated inflammation, FASEB J, vol.20, pp.2118-2138, 2006.

H. Zhang and M. Bhatia, Hydrogen sulfide: a novel mediator of leukocyte activation, Immunopharmacol. Immunotoxicol, vol.30, pp.631-676, 2008.

H. Zhang, S. M. Moochhala, and M. Bhatia, Endogenous hydrogen sulfide regulates inflammatory response by activating the ERK pathway in polymicrobial sepsis, J Immunol, vol.181, pp.4320-4351, 2008.

H. Zhang, L. Zhi, S. Moochhala, P. K. Moore, and M. Bathia, Hydrogen sulfide acts as an inflammatory mediator in cecal ligation and puncture-induced sepsis in mice by upregulation the production of cytokines and chemokines via NF-?B, Am J Physiol Lung Cell Mol Physiol, vol.292, pp.960-71, 2007.

H. Zhang, L. Zhi, P. K. Moore, and M. Bhatia, Role of hydrogen sulfide in cecal ligation and punctureinduced sepsis in the mouse, Am J Physiol Lung Cell Mol Physiol, vol.290, issue.6, pp.1193-1201, 2006.

W. Zhao, J. Zhang, Y. Lu, and R. Wang, The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener, EMBO J, vol.20, pp.6008-6024, 2001.

W. Zhao, J. Zhang, Y. Lu, and R. Wang, The vasorelaxant effect of H(2)S as a novel endogenous gaseous K(ATP) channel opener, EMBO J, vol.20, pp.6008-6024, 2001.

L. Zhi, A. Ang, H. Zhang, P. K. Moore, and M. Bathia, Hydrogen sulfide induces the synthesis proinflammatory cytokines in human monocyte cell line U937 via the ERK-NF-B pathway, J Leukoc Biol, vol.71, pp.1322-1354, 2007.

G. Z. Zhong, Y. B. Li, X. L. Liu, L. S. Guo, M. L. Chen et al., Hydrogen sulfide opens the KATP channel on rat atrial and ventricular myocytes, Cardiology, vol.115, issue.2, pp.120-126, 2010.